Onderneming Nanoantibiotics Inc Other OTC
Aandelen
US63009U1025
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 11-04-16 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 01-10-18 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-11-21 |
Penelope Markham
PRN | Corporate Officer/Principal | 58 | 01-11-18 |
Sarah Hoit
PRN | Corporate Officer/Principal | 57 | 01-02-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 16-06-20 |
Richard Berman
BRD | Director/Board Member | 81 | 24-06-19 |
Jim Lang
CHM | Chairman | 59 | 01-01-16 |
Director/Board Member | 65 | 16-06-20 | |
Sigmund Rogich
BRD | Director/Board Member | 80 | 16-06-20 |
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 11-04-16 |
Michael Sherman
BRD | Director/Board Member | 65 | 25-10-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 54 947 476 | 31 167 893 ( 56,72 %) | 22 880 ( 0,0416 %) | 56,72 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers BIVI
- Koers
- Onderneming Nanoantibiotics Inc